Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-Onset Type 1 Diabetes Mellitus

NCT01781975 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01781975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01781975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Imatinib for Preserving Beta-Cell Function in New-Onset Type 1 Diabetes Mellitus
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2014
Completion date
May 31, 2018
Enrollment
67 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, insulin-dependent, 1, diabetes mellitus, type i, iddm, insulin-dependent diabetes mellitus 1, type 1 diabetes mellitus